Intelligence Profile
Research Papers
Key Research Papers and Clinical Trials
Recent research on mesenchymal stem cell (MSC) therapy spans multiple medical conditions and approaches, though the evidence base varies significantly across applications.
Preclinical Research Findings
Several recent studies have explored MSC applications in different organ systems. Laboratory research has investigated the cardioprotective effects of human amniotic mesenchymal stem cells, though specific study details are limited in the available evidence. Other preclinical work has examined MSC-derived hepatocytes enhanced with compounds like quercetin for liver regeneration, and the potential of both adipose-derived stem cells and dental pulp stem cells for cartilage repair when grown on specialized scaffolds.
An emerging area of research focuses on MSC-derived exosomes (small vesicles released by cells) for treating eye surface disorders. Additional laboratory studies have explored using MSCs combined with antioxidants like glutathione for treating chemotherapy-induced mouth sores, and how iron-quercetin nanocomplex treatments might enhance MSCs' ability to promote wound healing.
However, one concerning finding suggests that MSCs might actually promote treatment resistance in certain types of lung cancer by altering how tumor cells process energy, highlighting the need for careful consideration of MSC therapy in cancer patients.
Clinical Trial Landscape
The clinical trial evidence for MSC therapy remains limited, with most studies being small-scale early-phase investigations. Available trials have examined MSC therapy for diverse conditions including female sexual dysfunction (Phase 2), erectile dysfunction in diabetic patients (Phase 1), and lupus kidney disease (Phase 2). One completed Phase 1/2 trial investigated MSC treatment for cerebellar ataxia, a neurological condition affecting coordination.
Evidence Limitations
Important note: The current evidence base for MSC therapy is still developing, with most clinical trials being early-phase studies with small patient numbers. The wide range of conditions being studied and different types of MSCs used make it difficult to draw broad conclusions about effectiveness and safety. Patients considering MSC therapy should discuss the limited evidence and experimental nature of these treatments with their healthcare providers.
This information is for educational purposes only and should not replace professional medical advice. Always consult with a qualified healthcare provider before making treatment decisions.